SCIENTIFIC PROGRAMME SNOLA UPDATE ON NEURO- ONCOLOGY 2016 24th March 13h 13h45 pathology case case parasellar meningeoma case : posterior fossa pediatric tumor 13h45 16h Imaging for CNS lymphomas Parasellar Tumors cranial Update on Imaging for pediatric posterior fossa challenges in lymphoma pathology Parasellar Tumors endoscopic Pathology overview in meduloblastomas Update on CNS Lymphoma treatment Update on molecular markers for medulloblastomas and treatment guidelines challenges of stereotatic biopsy Pineal cranial medulloblastomas role of second opinion in neuropathology Pineal Tumors endoscopic Update on molecular markers for pediatric gliomas and treatment guidelines State of the Art on radiation therapy for meduloblastoma Application and limitations of perfusion and espectroscopy MRI Clivus Surgical pediatric brainstem Applications and limitations of DTI and functional MRI Clivus Endoscopic Atypical ATRT tumor: Overview and future directions RANO criteria for gliomas Neuroblade: How does it work? Ependimoma: new classification and multidisciplinary treatment Rano criteria for brain Radiotherapy and reirradiation in
ependymoma 16h15-16h45 16h45-17h05 17h05-17h25 17h25-17h45 18h05-18h30 Lessons from TCGA; low grade gliomas Lessons from TCGA; high grade gliomas Treatment of low grade glioma SQUAD FIRING SESSION Section on low grade glioma 17h45-18h International 4 25th March 8h-8h40 pathology case case Eloquent area glioma case : Pediatric craniopharingeoma case 8h40-10h30 imaging for meningeomas subtypes Eloquent brain surgery planning Imaging for selar and suprasselar pathology and molecular markers for meningeomas Anatomy of speech areas and connections Pathology classification for craniopharingeomas Useful classifications for meningeoma surgery Premotor area: resectable or not? craniopharingeomas (endoscopic x open surgery) When should I irradiate a grade I meningioma? motor area and connections monitoring craniopharingeoma meningeomas Drainage veins and venous sinus: which and when coagulate? State of the Art on radiation therapy for Craniopharyngeoma Treatment for breast cancer brain e-anatomy and clinical applications How to define tumor progression X treatment effect
Treatment for lung cancer brain The role of immunotherapy and target therapy for melanoma brain Role of DTI in radiotherapy planning The role of PET-CT in brain Future directions of RANO 10h30-11h 11h-11h20 111h20-11h50 11h50-12h10 12h10-13h10 13h10-13h50 Pitffals in awake craniotomies Opening ceremony and awards Surgery for brain : is it still necessary? LUNCH Spinal pathology case pediatric low grade glioma 13h50-16h30 imaging in spinal pathological fracture Epidemiology of brain CBTRUS analysis Pathology and biology of pediatric low grade gliomas accuracy of percutaneous spinal lesion biopsy EORTC and RTOG protocols validation - a critical analysis Surgical treatment of low grade gliomas multiple mieloma treatment Genetic factors developing gliomas Treatment for unresectable low grade gliomas Surgical options for multiple mieloma fracture Cell phone use - is it a risk of developing brain AED in neurooncology imaging for spinal cord Advances in intraoperative monitoring for spinal cord WBRT cognitive protection Radiosurgery for gliomas Risk classification for low grade tumor patients temozolamide use for low grade gliomas spinal cord gliomas Applied anatomy retrosigmoid and far lateral approach Neoadjuvant chemotherapy for low grade
spinal cord ependimomas ependimomas Radiotherapy treatment for spinal cord Cavernous sinus anatomy craniotomy overview Cavernous sinus anatomy Endoscopic overview Ultrasound in glioma surgery Radiotherapy for HGG: the old and the new Applications of molecular markers in high grade gliomas Advances in surgical treatment for HGG Diffuse brainstem glioma: surgery x biopsy x no biopsy 16h30-17h 17h-17h20 17h20-17h40 17h40-18h 18h-18h20 18h20-18h30 20h The role of imri in glioma surgery what is next after temozolomide ERA of GBM; Novottf and other strategies Is there a role for target therapy for high grade gliomas The role of radiosurgery for surgical bed: where is the evidence? President s Dinner 26 th March ROOM 4 8h-8h40 Meeting the experts case Pituitary adenoma Meeting the experts Case Corpus calosum GBM Squad fire session Brain Meeting the experts case Pineal region tumor 8h40-10h20 imaging for selar and parasellar Thalamic anatomy and Epidemiology of brain and when should the brain be scanned pathology in germ cell pathology and molecular markers for pituitary adenomas Brainstem surgical GPA specific useful or already exceeded pineal region treatment guidelines
Clinical treatment for pituitary adenomas Indications, effectiveness and complications of Surgical treatment for vestibular schawnoma THermotherapy to brain Surgery in germ cell Chemotherapy for pituitary adenomas Is there a rule for target therapy for recurrent schawnoma radiosurgery to brain Chemotherapy and radiotherapy in germ cell Radiotherapy for pituitary adenomas: when and how? Is there a role of chemotherapy for brain oral presentations Invasive skull base and intraarterial chemotherapy WBRT for brain : when should we do it? Surgical treatment for oncological pain 10h20-10h50 10h50-11h10 11h10-11h30 11h30-11h50 11h50-12h10 12h10-13h10 13h10-13h50 Understanding immunology Immunotherapy in brain mets target therapy for brain mets Vaccines for gliomas LUNCH Spinal cord Neuro-oncology GBM 13h50-16h10 classifications of spinal pathological fracture SNOLA 2018 candidate presentations and board decision Imaging diagnosis of pseudoprogression and pseudoresponse surgery for spinal Difficulties in neurooncology in Brazil Correlation between molecular markers and
Thermotherapy for spinal Radiosurgery for compressive spinal immunotherapy for bone Surgery for sacral chordomas Radiotherapy and proton therapy for chordomas Chemotherapy for chordomas Clinical treatment for spinal pain Difficulties in neurosurgical oncology in Colombia Solutions and suggestions in neurooncology Neuro-oncology in Portugal: stand of care and research difficulties Neuro-pediatric oncology difficulties WFNOS proposals and suggestions discusssion imaging Molecular markers for GBM Neuroblade for GBM GBM stand of care treatment Alterantives for immunotherapy for GBM recurrent gbm The rule of reoperation for GBM GBM patients - when to stop treatment 16h10-16h40 16h40-17h 17h-17h20 17h20-17h40 17h40-18h 20h Delivered treatment for brain - is it useful? Advances in GBM surgery The role of bevacizumabe as first and second line treatment T cell check points in gliomas: promising? Closing Ceremony